TY - JOUR T1 - Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation JF - European Respiratory Journal JO - Eur Respir J SP - 453 LP - 461 DO - 10.1183/09031936.00015506 VL - 29 IS - 3 AU - M. Nakanishi AU - Y. Demura AU - S. Mizuno AU - S. Ameshima AU - Y. Chiba AU - I. Miyamori AU - H. Itoh AU - M. Kitaichi AU - T. Ishizaki Y1 - 2007/03/01 UR - http://erj.ersjournals.com/content/29/3/453.abstract N2 - High-resolution computed tomography (HRCT) findings in patients with respiratory bronchiolitis-associated interstitial lung disease (RB-ILD) are varied and nonspecific. There is no known report of changes in HRCT findings and respiratory function test results for RB-ILD patients following the cessation of smoking. Five patients with RB-ILD, confirmed by surgical lung biopsy, were retrospectively studied. Each stopped cigarette smoking and did not receive corticosteroid therapy after diagnosis. The clinical symptoms, respiratory function test results and HRCT findings obtained at the final observation were compared with those from the time of diagnosis. Ground-glass opacity and centrilobular nodules corresponding to pathological respiratory bronchiolitis, as well as intralobular fine linear-reticular opacity corresponding to fibrosis involving the subpleural alveolar septa, showed computed tomography–pathological correlations. Both clinical symptoms and the diffusing capacity of the lungs for carbon monoxide improved significantly following smoking cessation, as did ground-glass opacity and centrilobular nodules seen during the initial HRCT examination. Centrilobular nodules and ground-glass opacity, which are the main features of high-resolution computed tomography of respiratory bronchiolitis-associated interstitial lung disease patients and represent pathological respiratory bronchiolitis, can be improved by smoking cessation. The diffusing capacity of the lung for carbon monoxide in respiratory function tests can be also improved. ER -